TV TV L2 L2 (Lamivudine and zidovudine 150 mg / 300 mg)
Pill imprint TV TV L2 L2 has been identified as Lamivudine and zidovudine 150 mg / 300 mg.
Lamivudine/zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- TV TV L2 L2
- 150 mg / 300 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
Note: Inactive ingredients may vary.
More about lamivudine/zidovudine
- Other brands: Combivir
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.